Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Search Site

Over 2,750 Pages of
Hepatitis C Info, Here:
Hep C information
Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.
HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

Hepatitis C explained
My review of advice on Hepatitis C is split into section so that people who want information can find it fast without having to read endless babble that is of no help to their specific requirements. The sections of the review are as follows : 1.Who is

Hepatitis C does not slow down HIV recovery
Extract not available.

Natalie Cole Diagnosed with Hepatitis C
Grammy winner and songstress Natalie Cole has been diagnosed with Hepatitis C, according to many ongoing reports last week. Cole's publicist, Lellie Capwell released a statement to the public last Wednesday that the singer may have contracted the liver

UPDATES AND COMMENTARY RSS Feed

Natalie Cole Optimistic About Her Battle with Hepatitis C
Although currently recovering from combination therapy's side effects, the well-respected vocalist Natalie Cole may have conquered the Hepatitis C virus....

Hep C and Fatty Liver Disease Linked
Pittsburgh researchers have found an enzyme known to participate in fat production is elevated in those with Hepatitis C. Further exploration of this enzyme could help physicians better predict which HCV patients are at risk of developing fatty liver disease....

Anadys' ANA773 Hepatitis C Phase I Trials in Netherlands
Reducing the dosing schedule in half, Anadys Pharmaceuticals continues its investigation of ANA773, a Toll-Like Receptor-7 agonist prodrug. Approaching the Hepatitis C virus differently from most other contenders, Phase I clinical trials evaluating the safety, tolerability and viral-load decline associated...

Risk of Liver and Other Types of Cancer in Patients With Cirrhosis:
A Nationwide Cohort Study in Denmark

table  2.   Observed and Expected Numbers and SIR of Cancer in 11,605 Patients With Cirrhosis
Cancer Site Both Sexes
Men
Women
Observed Expected SIR 95% CI Observed SIR Observed SIR
All malignant neoplasms 1,447 708.1 2.0 1.9-2.2 896 2.2* 551 1.8*
Liver (primary) 245 6.8 36.0 31.6-40.8 182 40.2* 63 27.8*
  Hepatocellular carcinoma 199 3.3 59.9 51.8-68.8 152 59.5* 47 97.8*
  Cholangiocarcinoma 21 2.1 10.0 6.2-15.2 13 11.4* 8 8.3*
  Other and unspecified morphologies 25 1.4 18.3 11.8-27.0 17 20.6* 8 14.8*
Tobacco-related sites, total 356 188.6 1.9 1.7-2.1 244 1.8* 112 2.2*
  Lung 207 102.5 2.0 1.8-2.3 143 1.9* 64 2.5*
  Urinary bladder 62 45.8 1.4 1.0-1.7 47 1.3 15 1.7
  Kidney 45 20.1 2.2 1.6-3.0 27 2.1* 18 2.5*
  Pancreas 42 20.1 2.1 1.5-2.8 27 2.4* 15 1.7
Alcohol-related sites, totaldagger 241 31.3 7.7 6.8-8.7 173 7.0* 68 10.5*
  Buccal cavity and pharynx 143 15.5 9.2 7.8-10.8 96 8.1* 47 12.9*
  Esophagus 54 7.2 7.5 5.6-9.8 41 7.4* 13 7.7*
  Larynx 44 8.5 5.2 3.8-6.9 36 4.9* 8 7.1*
Hormone-related sites, total 151 135.4 1.1 0.9-1.3 42 1.0 109 1.2*
  Breast 83 63.7 1.3 1.0-1.6 2 3.2 81 1.3*
  Endometrium 14 16.5 0.9 0.5-1.4   ---   --- 14 0.9
  Ovary 14 13.7 1.0 0.6-1.7  ---   --- 14 1.0
  Prostate 40 41.6 1.0 0.7-1.3 40 1.0   ---   ---
Other sites, totalDagger 454 346.0 1.3 1.2-1.4 255 2.0* 199 1.3*
  Stomach 40 21.3 1.9 1.3-2.6 28 2.0* 12 1.7
  Colon 82 55.4 1.5 1.2-1.8 42 1.5* 40 1.5*
  Rectum 40 32.4 1.2 0.9-1.7 23 1.1 17 1.5
  Gallbladder and biliary tract 8 6.0 1.3 0.6-2.6 3 1.3 5 1.4
  Cervix uteri 11 10.4 1.1 0.5-1.9  ---   --- 11 1.1
  Testis 8 3.5 2.3 1.0-4.5 8 2.3  ---   ---
  Melanoma 8 15.2 0.5 0.2-1.0 2 0.3* 6 0.8
  Nonmelanoma skin 120 100.0 1.2 1.0-1.4 62 1.0 58 1.4*
  Brain and nervous system 9 17.2 0.5 0.2-1.0 5 0.5 4 0.6
  Thyroid 4 2.2 1.8 0.5-4.6 3 3.4 1 0.7
  Non-Hodgkin's lymphoma 19 14.9 1.3 0.8-2.0 12 1.4 7 1.2
  Leukemia 20 15.8 1.3 0.8-2.0 13 1.3 7 1.3
NOTE. First years of follow-up excluded.
* P < .05.
dagger Liver not included; sites also influenced by tobacco.
Dagger Not all sites shown.

Return To Article
  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 25 Jul 2008